πŸ‡ΊπŸ‡Έ FDA
Patent

US 9107956

Oligomer-protease inhibitor conjugates

granted A61KA61K47/60A61P

Quick answer

US patent 9107956 (Oligomer-protease inhibitor conjugates) held by Nektar Therapeutics expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K47/60, A61P, A61P31/12, A61P31/16